NorthCrest Asset Manangement’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $729K | Sell |
10,533
-230
| -2% | -$15.9K | 0.02% | 357 |
|
|
2025
Q1 | $747K | Sell |
10,763
-900
| -8% | -$62.5K | 0.02% | 348 |
|
|
2024
Q4 | $1M | Buy |
11,663
+495
| +4% | +$42.6K | 0.03% | 295 |
|
|
2024
Q3 | $1.33M | Buy |
11,168
+331
| +3% | +$39.4K | 0.04% | 249 |
|
|
2024
Q2 | $1.55M | Buy |
10,837
+232
| +2% | +$33.1K | 0.05% | 225 |
|
|
2024
Q1 | $1.36M | Buy |
10,605
+488
| +5% | +$62.7K | 0.05% | 239 |
|
|
2023
Q4 | $1.05M | Buy |
10,117
+73
| +0.7% | +$7.55K | 0.04% | 261 |
|
|
2023
Q3 | $913K | Hold |
10,044
| – | – | 0.04% | 269 |
|
|
2023
Q2 | $813K | Hold |
10,044
| – | – | 0.03% | 285 |
|
|
2023
Q1 | $799K | Buy |
10,044
+784
| +8% | +$62.4K | 0.03% | 291 |
|
|
2022
Q4 | $627K | Hold |
9,260
| – | – | 0.04% | 242 |
|
|
2022
Q3 | $461K | Hold |
9,260
| – | – | 0.03% | 313 |
|
|
2022
Q2 | $516K | Hold |
9,260
| – | – | 0.03% | 302 |
|
|
2022
Q1 | $514K | Buy |
+9,260
| New | +$514K | 0.02% | 294 |
|